 |
|
Major milestone in human genome story: Affymetrix launches the whole human genome on a single chip
October 02, 2003Affymetrix Announces Commercial Launch of Single Array for Human Genome Expression Analysis
-- More than 1 million probes analyze expression level of nearly 50,000 RNA transcripts and variants on a single array the size of a dime --
Santa Clara, Calif., Oct. 2, 2003 - Affymetrix, Inc., (NASDAQ: AFFX) today launched its new GeneChip® brand Human Genome U133 Plus 2.0 Array, offering researchers the transcribed human genome on a single commercially available catalog microarray. The HG-U133 Plus 2.0 Array analyzes the expression level of nearly 50,000 RNA transcripts and variants with 22 independent probes per transcript, providing superior data quality unmatched by technologies using a just single probe per transcript.
"With over 1 million probes on a commercial chip the size of a human thumbnail, the Human Plus array represents a leap in array technology data capacity, and further demonstrates the unique power and potential of our technology to explore vast areas of the genome," said Trevor J. Nicholls, Ph.D., Chief Commercial Officer. "Using multiple independent measurements for each transcript ensures that our data quality remains industry standard even as our data capacity increases dramatically."
The HG-U133 Plus 2.0 Array combines the content of the previous HG-U133 two-array set with nearly 10,000 new probe sets for a total of nearly 50,000 RNA transcripts and variants. This new information, verified against the actual genome map, provides researchers the most comprehensive and up-to-date genome-wide gene expression analysis. The probe design strategy of the HG-U133 Plus 2.0 Array is identical to the previous HG-U133 set and there is a very strong data concordance between the two arrays. With more than double the data capacity of the previous-generation Affymetrix human array, the HG-U133 Plus 2.0 Array can significantly cut processing and analysis time for scientists in the lab, freeing up valuable resources and accelerating research.
The HG-U133 Plus 2.0 Array offers the most genes and transcripts on any commercially available single array for human gene expression analysis, while maintaining Affymetrix' unrivaled data quality. Affymetrix uses 22 independent data points to measure the hybridization of each transcript on the array, more than a million data points in all and more than 30 times that of any other microarray technology. Using multiple measurements provides optimal sensitivity and specificity, and the most accurate, consistent and statistically significant results possible.
"More data points produce more reliable results and ultimately, better science," said Nicholls. "Our powerful probe set strategy gives our customers the assurance that what they see on the array reflects what is happening in their sample."
Affymetrix is also launching an updated 11-micron version of its popular HG-U133A Array called the GeneChip HG-U133A 2.0 Array. By reducing the feature size from 18-microns to 11-microns, the new HG-U133A 2.0 Array will enable researchers to use smaller sample volumes while maintaining its industry-standard performance. The new array represents over 14,000 well-characterized human genes that can be used to explore human biology and disease processes. All probe sets represented on the original GeneChip HG-U133A Array are identically replicated on the GeneChip HG-U133A 2.0 Array.
More information on the design of the HG-U133 Plus 2.0 Array and the HG-U133A 2.0 Array may be found on the Affymetrix website -- www.affymetrix.com.
Northbank Communications
"With over 1 million probes on a commercial chip the size of a human thumbnail, the Human Plus array represents a leap in array technology data capacity, and further demonstrates the unique power and potential of our technology to explore vast areas of the genome," said Trevor J. Nicholls, Ph.D., Chief Commercial Officer. "Using multiple independent measurements for each transcript ensures that our data quality remains industry standard even as our data capacity increases dramatically."
The HG-U133 Plus 2.0 Array combines the content of the previous HG-U133 two-array set with nearly 10,000 new probe sets for a total of nearly 50,000 RNA transcripts and variants. This new information, verified against the actual genome map, provides researchers the most comprehensive and up-to-date genome-wide gene expression analysis. The probe design strategy of the HG-U133 Plus 2.0 Array is identical to the previous HG-U133 set and there is a very strong data concordance between the two arrays. With more than double the data capacity of the previous-generation Affymetrix human array, the HG-U133 Plus 2.0 Array can significantly cut processing and analysis time for scientists in the lab, freeing up valuable resources and accelerating research.
The HG-U133 Plus 2.0 Array offers the most genes and transcripts on any commercially available single array for human gene expression analysis, while maintaining Affymetrix' unrivaled data quality. Affymetrix uses 22 independent data points to measure the hybridization of each transcript on the array, more than a million data points in all and more than 30 times that of any other microarray technology. Using multiple measurements provides optimal sensitivity and specificity, and the most accurate, consistent and statistically significant results possible.
"More data points produce more reliable results and ultimately, better science," said Nicholls. "Our powerful probe set strategy gives our customers the assurance that what they see on the array reflects what is happening in their sample."
Affymetrix is also launching an updated 11-micron version of its popular HG-U133A Array called the GeneChip HG-U133A 2.0 Array. By reducing the feature size from 18-microns to 11-microns, the new HG-U133A 2.0 Array will enable researchers to use smaller sample volumes while maintaining its industry-standard performance. The new array represents over 14,000 well-characterized human genes that can be used to explore human biology and disease processes. All probe sets represented on the original GeneChip HG-U133A Array are identically replicated on the GeneChip HG-U133A 2.0 Array.
More information on the design of the HG-U133 Plus 2.0 Array and the HG-U133A 2.0 Array may be found on the Affymetrix website -- www.affymetrix.com.
Northbank Communications
Genome Current Events and Genome News RSSMetabolic reactions: Less is more in single-celled organisms
A Northwestern University study has found a surprising similarity among four quite different organisms. The simplest organism, a bacterium called H. pylori, uses the same number of biochemical reactions (around 300) as yeast, the largest, most complex organism of the group, when optimizing growth.
Plants display 'molecular amnesia'
Plant researchers from McGill University and the University of California, Berkeley, have announced a major breakthrough in a developmental process called epigenetics. They have demonstrated for the first time the reversal of what is called epigenetic silencing in plants.
Research in twins defines shared features of the human gut microbial communities: variations linked to obesity
Trillions of microbes make their home in the gut, where they help to break down and extract energy and nutrients from the food we eat. Yet, scientists have understood little about how this distinctive mix of microbes varies from one individual to the next.
Tool Helps Identify Gene Function in Soybeans, Could Lead to Better Crop Performance, say MU Researchers
In the race for bioengineered crops, sequencing the genome could be considered the first leg in a multi-leg relay.
Ice beetles impacted by climate change
In the summer of 1968, Dave Kavanaugh set off on a hike that would change the course of his life. As a second-year medical student at the University of Colorado, he had joined a climbing club with a few members of the biophysics department, and the group had set their sights on Gray's Peak-the ninth highest mountain in Colorado.
Stanford blood scanner detects even faint indicators of cancer
A team led by Stanford researchers has developed a prototype blood scanner that can find cancer markers in the bloodstream in early stages of the disease, potentially allowing for earlier treatment and dramatically improved chances of survival.
CSHL scientists discover a new way in which epigenetic information is inherited
Hereditary information flows from parents to offspring not just through DNA but also through the millions of proteins and other molecules that cling to it.
Solar-Powered Sea Slugs Live Like Plants
The lowly sea slug, "Elysia chlorotica," may not seem like the most exciting of creatures, but don't be fooled: it behaves like a plant and is solar-powered, says a Texas A&M University biologist who has been studying these tiny creatures for the past decade and, along with collaborators from several universities, has identified a possible cause of their ability to behave like plants.
Researchers recreate SARS virus, open door for potential defenses against future strains
Researchers at the University of North Carolina at Chapel Hill and Vanderbilt University Medical Center have synthetically reconstructed the bat variant of the SARS coronavirus (CoV) that caused the SARS epidemic of 2003.
Synthetic virus supports a bat origin for SARS
SARS - severe acute respiratory syndrome - alarmed the world five years ago as the first global pandemic of the 21st century. The coronavirus (SARS-CoV) that sickened more than 8,000 people - and killed nearly 800 of them - may have originated in bats, but the actual animal source is not known.
More Genome Current Events and Genome News Articles
 | Genome: The Autobiography of a Species in 23 Chapters (P.S.) by Matt Ridley The genome's been mapped. But what does it mean? Arguably the most significant scientific discovery of the new century, the mapping of the twenty-three pairs of chromosomes that make up the human genome raises almost as many questions as it answers. Questions that will profoundly impact the way we think about disease, about longevity, and about free will. Questions that will affect the rest... |
 | Genetic Entropy & the Mystery of the Genome by John C Sanford Dr. John Sanford, a retired Cornell Professor, shows in "Genetic Entropy and the Mystery of the Genome" that the "Primary Axiom" is false. The Primary Axiom is the foundational evolutionary premise -- that life is merely the result of mutations and natural selection. In addition to showing compelling theoretical evidence that whole genomes must in fact degenerate over time, this book strongly... |
 | Medical Firsts: From Hippocrates to the Human Genome by Robert E. Adler An exploration of medical discoveries-from the ancient Greeks to the present "Always help, or at least do no harm." Following this simple yet revolutionary idea, Hippocrates laid the foundation for modern medicine over two millennia ago. From the Hippocratic Oath to the human genome, from Pasteur's germ theory to the worldwide eradication of smallpox, Medical Firsts brings to life 2,500 years... |
 | Genetics: From Genes to Genomes (3rd Edition Study Guide) by Leland Hartwell, Leroy Hood, Michael L. Goldberg, Ann E. Reynolds, Lee M. Silver, Ruth C. Veres Genetics: From Genes to Genomes is a cutting-edge, introductory genetics text authored by an unparalleled author team, including Nobel Prize winner, Leland Hartwell. The Second Edition continues to build upon the integration of Mendelian and molecular principles, providing students with the links between early genetics understanding and the new molecular discoveries that have changed the way... |
 | The Genome War: How Craig Venter Tried to Capture the Code of Life and Save the World by James Shreeve The long-awaited story of the science, the business, the politics, the intrigue behind the scenes of the most ferocious competition in the history of modern science—the race to map the human genome.On May 10, 1998, biologist Craig Venter, director of the Institute for Genomic Research, announced that he was forming a private company that within three years would unravel the complete genetic... |
 | Short Guide to the Human Genome by Stewart Scherer How many genes are in the human genome? Which genes are commonly associated with genetic diseases? How many mobile elements, simple sequence repeats, or protein kinases are encoded in the genome? What are the largest genes and proteins? How similar are human proteins to those of mouse, yeast, or bacteria? Although the human genome has been sequenced, it often can be surprisingly difficult to... |
 | The Origins of Genome Architecture by Michael Lynch The availability of genomic blueprints for hundreds of species has led to a transformation in biology, encouraging the proliferation of adaptive arguments for the evolution of genomic features, yet often sacrificing simpler, more compelling explanations. This textbook explains why the details matter and presents an explanatory framework for how the architectural diversity of eukarotic genomes and... |
 | Welcome to the Genome: A User's Guide to the Genetic Past, Present, and Future by Rob DeSalle, Michael Yudell, American Museum of Natural History A thrilling "user's guide" to the genomics era Welcome to the genome, the miraculous blueprint of your DNA, coiled tight as a spring in the nucleus of each cell of your body. If unwound, the DNA from just one cell, while only a molecule in width, would stretch six feet in length! The information stored in its double helix structure - three billion bits worth - could fill 142 Manhattan... |
 | Acquiring Genomes: The Theory of the Origins of the Species by Lynn Margulis, Dorion Sagan From one of the great iconoclasts of modern biology, Lynn Margulis, a groundbreaking new theory of the origins of species. How do new species evolve? Although Darwin identified inherited variation as the creative force in evolution, he never formally speculated where it comes from. His successors thought that new species arise from the gradual accumulation of random mutations of DNA. But... |
 | The Global Genome: Biotechnology, Politics, and Culture (Leonardo Books) by Eugene Thacker In the age of global biotechnology, DNA can exist as biological material in a test tube, as a sequence in a computer database, and as economically valuable information in a patent. In The Global Genome, Eugene Thacker asks us to consider the relationship of these three entities and argues that—by their existence and their interrelationships—they are fundamentally redefining the notion of... |
| © 2008 BrightSurf.com |